Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced a connected transaction involving a capital increase in Baiyunshan Biological. This transaction includes a profit forecast based on an income approach appraisal, which has been reviewed by the company’s auditors and confirmed by the board. The announcement provides additional information required by the Hong Kong Listing Rules, ensuring transparency and compliance.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability based in the People’s Republic of China. The company operates in the pharmaceutical industry, focusing on the development and production of pharmaceutical products.
YTD Price Performance: -0.55%
Average Trading Volume: 1,335,345
Technical Sentiment Signal: Hold
Current Market Cap: HK$45.1B
For an in-depth examination of 0874 stock, go to TipRanks’ Overview page.